8-K
filed April 13, 2026, 7:59 PM ET
ticker CCTC
CIK 0001477960
other material
confidence high
sentiment neutral
materiality 0.60
LataMed AI Corp. (CCTC): M&A transaction — Catalyst Crew acquires AI healthcare IP and Venezuelan subsidiary from CEO in related-party transactions
LataMed AI Corp.
- Acquired AI healthcare analytics IP (CardioAI, PulmoAI, NeuroAI) from CEO via APA dated Feb 17, 2026.
- Acquired 100% of Inversiones Long 33, C.A. from CEO on March 23, 2026; now wholly-owned subsidiary.
- IP formally assigned to subsidiary on April 7, 2026 as internal reorganization; no additional consideration.
- Press releases issued March-April 2026 announcing CardioAI, PulmoAI, NeuroAI platforms and operating structure.
Key facts
Extracted from this filing and checked against the source text.
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
LataMed AI Corp. completed an acquisition involving Kevin Rodan Levy (closed 2026-03-23).
- Action
- acquisition
- Counterparty
- Kevin Rodan Levy
- Closing
- 2026-03-23
Exact text from the filing
On March 23, 2026, the Company completed the acquisition of one hundred percent (100%) of the issued and outstanding shares of Inversiones Long 33, C.A. pursuant to a Share Assignment Agreement with Kevin Rodan Levy.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
LataMed AI Corp. entered into Asset Purchase Agreement with Kevin Rodan Levy (effective 2026-02-17).
- Action
- entry
- Agreement
- asset purchase
- Counterparty
- Kevin Rodan Levy
- Effective
- 2026-02-17
Exact text from the filing
On February 17, 2026, Catalyst Crew Technologies Corp. (the “Company”) entered into an Asset Purchase Agreement (the “APA”) with its Chief Executive Officer, Kevin Rodan Levy (the “Seller”), pursuant to which the Company acquired certain assets, including intellectual property relating to an artificial intelligence-enabled healthcare analytics platform.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
LataMed AI Corp. entered into Intellectual Property Assignment Agreement with Kevin Rodan Levy (effective 2026-04-07).
- Action
- entry
- Counterparty
- Kevin Rodan Levy
- Effective
- 2026-04-07
Exact text from the filing
On April 7, 2026, the Seller entered into an Intellectual Property Assignment Agreement with the Subsidiary, pursuant to which certain intellectual property rights previously acquired by the Company pursuant to the APA were formally assigned to the Subsidiary, including:
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
LataMed AI Corp. entered into Share Assignment Agreement with Kevin Rodan Levy (effective 2026-03-23).
- Action
- entry
- Agreement
- asset purchase
- Counterparty
- Kevin Rodan Levy
- Effective
- 2026-03-23
Exact text from the filing
On March 23, 2026, the Company entered into a Share Assignment Agreement with Seller pursuant to which the Company acquired one hundred percent (100%) of the issued and outstanding shares of Inversiones Long 33, C.A., a corporation organized under the laws of the Bolivarian Republic of Venezuela (the “Subsidiary”).
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.